Morningstar Investor users sign in here.

Company Profile

  • Business description

    HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

  • Contact

    2 Queen's Road Central
    48th Floor, Cheung Kong Center
    Hong Kong
    HKG

    T: +852 21218200

    E: ir@chi-med.com

    https://www.hutch-med.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    1,990

HUTCHMED (China) Ltd News & Analysis

stocks

These Chinese stocks are at risk of being delisted from US exchanges

Five companies, including Yum China, may delist by 2024 if they are unable to comply with US auditing standards.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,906.60 69.20 0.88%
CAC 40 8,076.34 11.90 -0.15%
DAX 40 18,137.41 23.60 -0.13%
Dow JONES (US) 38,330.84 91.18 0.24%
FTSE 100 8,157.12 17.29 0.21%
HKSE 17,746.91 95.76 0.54%
NASDAQ 15,972.72 44.82 0.28%
Nikkei 225 37,934.76 306.28 0.81%
NZX 50 Index 11,916.24 111.15 0.94%
S&P 500 5,114.02 14.06 0.28%
S&P/ASX 200 7,637.40 61.50 0.81%
SSE Composite Index 3,113.04 24.41 0.79%

Market Movers

Name
Last price
Change
% Change
The Star Entertainment Group Ltd SGR 0.42 0.03 6.41%
Sayona Mining Ltd SYA 0.03 0.00 0.00%
Droneshield Ltd DRO 0.80 0.04 -4.22%
Mesoblast Ltd MSB 1.09 0.16 16.67%
South32 Ltd S32 3.51 0.14 4.15%
Pilbara Minerals Ltd PLS 3.96 0.16 4.21%
Telstra Group Ltd TLS 3.66 0.02 0.55%
Northern Minerals Ltd NTU 0.03 0.00 6.25%
Jupiter Mines Ltd JMS 0.32 0.02 5.00%
Imugene Ltd IMU 0.08 0.00 3.80%